| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | 2026-01-17 | 13,951 | $7.42 | $103.52kSell |
| Alexandria Forbes | PRESIDENT CEO | 2026-01-17 | 163,916 | $7.42 | $1.22MSell |
| Richard Giroux | CFO COO | 2026-01-17 | 163,916 | $7.42 | $1.22MSell |
| Stuart Naylor | CHIEF DEV. OFFICER | 2026-01-17 | 35,250 | $7.42 | $261.56kSell |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2026-01-17 | 27,206 | $7.42 | $201.87kSell |
| Alexandria Forbes | PRESIDENT CEO | 2026-01-07 | 34,074 | $7.73 | $263.39kSell |
| Richard Giroux | CFO COO | 2026-01-07 | 28,822 | $7.73 | $222.79kSell |
| Stuart Naylor | CHIEF DEV. OFFICER | 2026-01-07 | 17,625 | $7.73 | $136.24kSell |
| Robert K. Zeldin | CHIEF MEDICAL OFFICER | 2026-01-07 | 6,729 | $7.73 | $52.02kSell |
| Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2026-01-07 | 4,364 | $7.73 | $33.73kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Sanofi | 15.15% | 12,197,737 | $92.46M | Insider |
| Sanofi | 15.15% | 12,197,737 | $92.46M | Institution |
| Perceptive Advisors LLC | 12.71% | 10,231,103 | $77.55M | Insider |
| Johnson Johnson | 8.25% | 6,641,064 | $50.34M | Institution |
| Johnson Johnson | 8.25% | 6,641,064 | $50.34M | Insider |
| Johnson Innovatio Johnson | 8.25% | 6,641,064 | $50.34M | Insider |
| Rubric Capital Management LP | 7.67% | 6,175,331 | $46.81M | Institution |
| Perceptive Life Sciences Master Fund Ltd | 7.46% | 6,007,746 | $45.54M | Insider |
| Prosight Management LP | 3.99% | 3,209,788 | $24.33M | Institution |
| Blackrock Inc | 3.81% | 3,069,844 | $23.27M | Institution |